These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1491 related articles for article (PubMed ID: 33363020)
1. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma. Ma C; Kang W; Yu L; Yang Z; Ding T Front Oncol; 2020; 10():590006. PubMed ID: 33363020 [TBL] [Abstract][Full Text] [Related]
2. Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma. Xu H; Xiong C; Chen Y; Zhang C; Bai D Bioengineered; 2021 Dec; 12(1):2664-2675. PubMed ID: 34115569 [TBL] [Abstract][Full Text] [Related]
3. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma. Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633 [TBL] [Abstract][Full Text] [Related]
4. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers. Wang N; Zhu L; Wang L; Shen Z; Huang X Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736 [TBL] [Abstract][Full Text] [Related]
5. Identifies microtubule-binding protein Wang W; Zhang J; Wang Y; Xu Y; Zhang S Comput Struct Biotechnol J; 2022; 20():3322-3335. PubMed ID: 35832625 [TBL] [Abstract][Full Text] [Related]
6. HMMR associates with immune infiltrates and acts as a prognostic biomaker in lung adenocarcinoma. Ma X; Xie M; Xue Z; Yao J; Wang Y; Xue X; Wang J Comput Biol Med; 2022 Dec; 151(Pt A):106213. PubMed ID: 36306573 [TBL] [Abstract][Full Text] [Related]
7. Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma. Qin Z; Xie B; Qian J; Ma X; Zhang L; Wei J; Wang Z; Fan L; Zhu Z; Qian Z; Yin H; Zhu F; Tan Y Front Oncol; 2023; 13():1144269. PubMed ID: 37056349 [TBL] [Abstract][Full Text] [Related]
8. Significance of Lin H; Wang J; Shi Q; Wu M PeerJ; 2024; 12():e17338. PubMed ID: 38708353 [TBL] [Abstract][Full Text] [Related]
9. Bioinformatic prediction of miR-320a as a potential negative regulator of CDGSH iron-sulfur domain 2 ( Zhao X; Li L; Li Y; Liu Y; Wang H; Tabrizi NS; Ye Z; Zhao Z Transl Cancer Res; 2024 Aug; 13(8):4485-4499. PubMed ID: 39262456 [TBL] [Abstract][Full Text] [Related]
10. Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma. Yang Z; Liang X; Fu Y; Liu Y; Zheng L; Liu F; Li T; Yin X; Qiao X; Xu X EBioMedicine; 2019 Sep; 47():44-57. PubMed ID: 31409573 [TBL] [Abstract][Full Text] [Related]
11. Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches. Jiang J; Zhang Y; Wang J; Yang X; Ren X; Huang H; Wang J; Lu J; Zhong Y; Lin Z; Lin X; Jia Y; Lin S PeerJ; 2023; 11():e16166. PubMed ID: 37790630 [TBL] [Abstract][Full Text] [Related]
12. Zheng X; Han L; Guan J; Chen C; Zhang Y; Zhang J; Zhang Y; Liu S; Su J; Liu M; Huang H Front Oncol; 2023; 13():1274439. PubMed ID: 38152367 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis identifies DNA damage repair-related gene HCLS1 associated with good prognosis in lung adenocarcinoma. Liu T; Hu A; Chen H; Li Y; Wang Y; Guo Y; Liu T; Zhou J; Li D; Chen Q Transl Cancer Res; 2023 Oct; 12(10):2613-2628. PubMed ID: 37969376 [TBL] [Abstract][Full Text] [Related]
14. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma. Zuo S; Wei M; Wang S; Dong J; Wei J Front Immunol; 2020; 11():1218. PubMed ID: 32714316 [No Abstract] [Full Text] [Related]
15. DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinoma. Wu YJ; Nai AT; He GC; Xiao F; Li ZM; Tang SY; Liu YP; Ai XH World J Surg Oncol; 2021 Sep; 19(1):274. PubMed ID: 34517904 [TBL] [Abstract][Full Text] [Related]
16. A signature of tumor DNA repair genes associated with the prognosis of surgically-resected lung adenocarcinoma. Yang X; Wang G; Gu R; Xu X; Zhu G PeerJ; 2020; 8():e10418. PubMed ID: 33304656 [TBL] [Abstract][Full Text] [Related]
17. Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma. Zhuo X; Chen L; Lai Z; Liu J; Li S; Hu A; Lin Y Bioengineered; 2021 Dec; 12(1):8336-8346. PubMed ID: 34592886 [TBL] [Abstract][Full Text] [Related]
18. ECE2 is a prognostic biomarker associated with m6A modification and involved in immune infiltration of lung adenocarcinoma. Zhang YH; Zeng J; Liu XS; Gao Y; Kui XY; Liu XY; Zhang Y; Pei ZJ Front Endocrinol (Lausanne); 2022; 13():1013238. PubMed ID: 36299451 [TBL] [Abstract][Full Text] [Related]
19. Identification of ALG3 as a potential prognostic biomarker in lung adenocarcinoma. Yuan Y; Xie B; Guo D; Liu C; Jiang G; Lai G; Zhang Y; Hu X; Wu Z; Zheng R; Huang L Heliyon; 2023 Jul; 9(7):e18065. PubMed ID: 37539167 [TBL] [Abstract][Full Text] [Related]
20. UBR1 is a prognostic biomarker and therapeutic target associated with immune cell infiltration in gastric cancer. Yuan W; Han J; Chen C; Qiu Y; Xu Y; Huang Y; Chen Z; Xu A; Sun M Aging (Albany NY); 2024 Aug; 16(16):12029-12049. PubMed ID: 39181686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]